Dr. Joan Mannick — mTOR’s Role in Aging
Targeting the biology of ageing to prevent, treat and reverse age-related diseases | Dr Joan Mannick
Targeting Aging Biology to treat aging related diseases by Joan Mannick
Joan Mannick at ARDD2023 - Longevity Medicine Day: Longevity medicine therapeutics applied gero...
Joan Mannick on Rapamycin Longevity Series | Turning down mTOR to young levels may be good for aging
Dr. Joan Mannick
Treatment of Aging Related Diseases - TORC1
Agingdoc HealthspanCoaching com Feature Courtesy Hevolution Foundation Joan Mannick
Joan Mannick, ResTORbio CMO, at the Longevity Leaders Congress (May 2020)
The BEST Validated Therapeutic To EXTEND LIFESPAN
Joan Mannick, MD: The Future of RTB101
Webinar | Joan Mannick, PhD | TORC1 & RTB101 to Improve Immune Health, Decrease COVID-19 Severity
492: Investigating Novel Therapeutics to Improve Immune Function and Treat Age-Related Diseases -...
Joan Mannick, MD, on TORC1 Inhibition
#123–Joan Mannick & Nir Barzilai: Rapamycin and metformin—longevity, immune enhancement, & COVID-19
#Ageing science, #healthspan and the potential to dramatically change how we treat disease
Turning Back Time: The Science of Aging
Rapamycin study shows extreme life extension results
mTOR Inhibitors Human Trials : Reversal Of Aged Immune System
Roadmap to commercialisation – examining clinical and regulatory pathways for longevity therapeutics